References
- Herdman R C. Statement on Health Care Technology and Issues of Health Systems Reform. Committee on Energy and Commerce, Subcommittee on Health and the Environment. U.S. House of Representatives. Oct 31, 1991
- Hadley J, Steinberg E P, Feder J. Comparison of uninsured and privately insured hospital patients. JAMA 1991; 265: 374–379
- Wenneker M B, Weissman J S, Epstein A M. The association of payer with utilization of cardiac procedures in Massachusetts. JAMA 1990; 264: 1255–1260
- Lazenby H C, Letsch S. National health expenditures. Health Care Financing Rev 1990; 12: l–26
- Office of Technology Assessment. U.S. Congress, The Costs of AIDS and other HIV Infections: Review of the Estimates, Staff Paper 1987
- Office of Technology Assessment. U.S. Congress, Medical Technology and Cost of the Medicare Program, OTA-H-227. U.S. Government Printing Office, Washington, DC 1984
- Office of Technology Assessment. U.S. Congress, Federal Policies and the Medical Devices Industry, OTA-H-229. U.S. Government Printing Office, Washington, DC 1984
- Office of Technology Assessment. U.S. Congress, Medicare's Prospective Payment System, OTA-H-262. U.S. Government Printing Office, Washington, DC 1986
- Office of Technology Assessment. U.S. Congress, Payment for Physicians Services: Implications for Medicare, OTA-H-294. U.S. Government Printing Office, Washington, DC 1986
- Office of Technology Assessment. U.S. Congress, Life Sustaining Technologies and the Elderly, OTA-BA-306. U.S. Government Printing Office, Washington, DC 1987
- Office of Technology Assessment. U.S. Congress, The Quality of Medical Care: Information for Consumers, OTA-H-386. U.S. Government Printing Office, Washington, DC 1988
- Office of Technology Assessment. U.S. Congress, The Implications of Cost-Effectiveness Analysis of Medical Technology, OTA-H-126. U.S. Government Printing Office, Washington, DC 1980
- Garber A M, Wagner J L. Practice guidelines and cholesterol policy. Health Aff (Millwood) Summer, 1991
- Winslow C M, Kosecoff J B, Chassin M. The appropriateness of performing coronary artery bypass surgery. JAMA 1988; 260: 505–509
- Beutler E. Gaucher's disease. N Engl J Med 1991; 325: 1354–1360
- Krahn M, Naylor C D, Basinski A S. Comparison of an aggressive (U.S.) and a less aggressive (Canadian) policy for cholesterol screening and treatment. Ann Intern Med 1991; 115: 248–255
- Matthal WT, Jr, Hirshfeld FW, Jr. Choice of contrast agents for cardiac angiography: Review and recommendations based on clinically important distinctions. Cath Cardiovasc Diag 1991; 22: 278–289
- Linton A L, Naylor C D. Organized medicine and the assessment of technology. N Engl J Med 1990; 323: 1463–1467
- Conseil d'Evaluation des Technologies de la Sante du Quebec. Evaluation of Low vs High Osmolar Contrast Media 1990
- Hlatky M A, Moms K G, Pieper K S. Randomized comparison of the cost and effectiveness of Iopamidol and Diatrizoate as contrast agents for cardiac angiography. J Am Coll Cardiol 1990; 16: 871–877
- Goel V, Deber R B, Detsky A S. Nonionic contrast media: Economic analysis and health policy development. Can Med Assoc J 1989; 140: 389–395
- Palmer F J. The RACR survey of intravenous contrast media reactions final report. Australas Radiol 1988; 32: 426–428
- Current Criteria for the Use of Water Soluble Contrast Agents for Intravenous Injections. American College of Radiology, Reston, VA 1990
- Mishkin M. Use of iodinated contrast agents: Principles and practice. Decisions imaging Econ 1991; 4(4)4–17
- McClennan B. Ionic and nonionic iodinated contrast media: Evolution and strategies for use. AJR 1990; 155: 225–233
- Hatziandreu E, Carlson K, Mulley AG, Jr. Cost-effectiveness study of the extracorporeal shock-wave lithotriptor. Int J Tech Assess Health Care 1990; 6: 623–632
- Office of Technology Assessment. U.S. Congress, Effects of Federal Policies on Extracorporeal Shock Wave Lithotripsy, OTA-HCS-36. U.S. Government Printing Office, Washington, DC 1986
- Power E J. The adoption and use of extracorporeal shock-wave lithotripsy by hospitals in the United States. Int J Tech Assess Health Care 1987; 3: 397–404
- Bloom B, Hillman A, Schwartz J S. Abruptly changing patterns of diffusion and use of extracorporeal shock-wave lithotripsy. Am J Kidney Dis 1991; 18(1)103–107
- Office of Technology Assessment. U.S. Congress, Recombinant Erythropoietin: Payment Options for Medicare, OTA-H-451. U.S. Government Printing Office, Washington, DC 1990
- Sisk J, Gianfrancesco F, Coster J. Recombinant erythropoietin and Medicare payment. JAMA 1991; 266: 247–252